Cargando…
Cyclooxygenase-2 Inhibition as an Add-On Strategy in Drug Resistant Epilepsy—A Canine Translational Study
Drug-resistant epilepsy is a common complaint in dogs and affects up to 30% of dogs with idiopathic epilepsy. Experimental data suggest that targeting cyclooxygenase-2 (COX-2) mediated signaling might limit excessive excitability and prevent ictogenesis. Moreover, the role of COX-2 signaling in the...
Autores principales: | Fischer, Andrea, Hülsmeyer, Velia-Isabel, Munoz Schmieder, Viviana P., Tipold, Andrea, Kornberg, Marion, König, Florian, Gesell, Felix K., Ahrend, Liza K., Volk, Holger A., Potschka, Heidrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021788/ https://www.ncbi.nlm.nih.gov/pubmed/35464372 http://dx.doi.org/10.3389/fvets.2022.864293 |
Ejemplares similares
-
Pregabalin Add-On vs. Dose Increase in Levetiracetam Add-On Treatment: A Real-Life Trial in Dogs With Drug-Resistant Epilepsy
por: Kriechbaumer, Sandra R. P., et al.
Publicado: (2022) -
Neurostimulation as a Method of Treatment and a Preventive Measure in Canine Drug-Resistant Epilepsy: Current State and Future Prospects
por: Nowakowska, Marta, et al.
Publicado: (2022) -
Antiepileptic Drug Withdrawal in Dogs with Epilepsy
por: Gesell, Felix Kaspar, et al.
Publicado: (2015) -
Molecular alterations of the TLR4-signaling cascade in canine epilepsy
por: von Rüden, Eva-Lotta, et al.
Publicado: (2020) -
International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy
por: Potschka, Heidrun, et al.
Publicado: (2015)